Bis(4-(5-tert-butyl-4-methyl-1H-pyrazol-3-yl)quinazoline);4-(5-tert-butyl-1H-1,2,4-triazol-3-yl)pyrimidine;4-(5-methyl-1H-pyrazol-3-yl)-N-phenyl-N-[6-[5-(trifluoromethyl)-1H-pyrazol-3-yl]pyrimidin-4-yl]pyrimidin-2-amine
C64H65F3N22 — CID 159623445
Data last refreshed: (MolForge compound catalog, from PubChem)
About Bis(4-(5-tert-butyl-4-methyl-1H-pyrazol-3-yl)quinazoline);4-(5-tert-butyl-1H-1,2,4-triazol-3-yl)pyrimidine;4-(5-methyl-1H-pyrazol-3-yl)-N-phenyl-N-[6-[5-(trifluoromethyl)-1H-pyrazol-3-yl]pyrimidin-4-yl]pyrimidin-2-amine
Bis(4-(5-tert-butyl-4-methyl-1H-pyrazol-3-yl)quinazoline);4-(5-tert-butyl-1H-1,2,4-triazol-3-yl)pyrimidine;4-(5-methyl-1H-pyrazol-3-yl)-N-phenyl-N-[6-[5-(trifluoromethyl)-1H-pyrazol-3-yl]pyrimidin-4-yl]pyrimidin-2-amine (PubChem CID 159623445) has the molecular formula C64H65F3N22 and a molecular weight of 1199.37 g/mol. Its IUPAC name is bis(4-(5-tert-butyl-4-methyl-1H-pyrazol-3-yl)quinazoline);4-(5-tert-butyl-1H-1,2,4-triazol-3-yl)pyrimidine;4-(5-methyl-1H-pyrazol-3-yl)-N-phenyl-N-[6-[5-(trifluoromethyl)-1H-pyrazol-3-yl]pyrimidin-4-yl]pyrimidin-2-amine.
Molecular Properties
| Compound Name | Bis(4-(5-tert-butyl-4-methyl-1H-pyrazol-3-yl)quinazoline);4-(5-tert-butyl-1H-1,2,4-triazol-3-yl)pyrimidine;4-(5-methyl-1H-pyrazol-3-yl)-N-phenyl-N-[6-[5-(trifluoromethyl)-1H-pyrazol-3-yl]pyrimidin-4-yl]pyrimidin-2-amine |
|---|---|
| PubChem CID | 159623445 |
| Molecular Formula | C64H65F3N22 |
| Molecular Weight | 1199.37 g/mol |
| Exact Mass | 1198.57 |
| IUPAC Name | bis(4-(5-tert-butyl-4-methyl-1H-pyrazol-3-yl)quinazoline);4-(5-tert-butyl-1H-1,2,4-triazol-3-yl)pyrimidine;4-(5-methyl-1H-pyrazol-3-yl)-N-phenyl-N-[6-[5-(trifluoromethyl)-1H-pyrazol-3-yl]pyrimidin-4-yl]pyrimidin-2-amine |
| SMILES | CC(C)(C)c1nc(-c2ccncn2)n[nH]1.Cc1c(-c2ncnc3ccccc23)n[nH]c1C(C)(C)C.Cc1c(-c2ncnc3ccccc23)n[nH]c1C(C)(C)C.Cc1cc(-c2ccnc(N(c3ccccc3)c3cc(-c4cc(C(F)(F)F)[nH]n4)ncn3)n2)n[nH]1 |
| InChI | InChI=1S/C22H16F3N9.2C16H18N4.C10H13N5/c1-13-9-17(31-30-13)15-7-8-26-21(29-15)34(14-5-3-2-4-6-14)20-11-16(27-12-28-20)18-10-19(33-32-18)22(23,24)25;2*1-10-13(19-20-15(10)16(2,3)4)14-11-7-5-6-8-12(11)17-9-18-14;1-10(2,3)9-13-8(14-15-9)7-4-5-11-6-12-7/h2-12H,1H3,(H,30,31)(H,32,33);2*5-9H,1-4H3,(H,19,20);4-6H,1-3H3,(H,13,14,15) |
| InChIKey | MOEMTQCCQSDVNP-UHFFFAOYSA-N |
| XLogP | 13.65 |
| TPSA | 288.43 Ų |
| H-Bond Donors | 5 |
| H-Bond Acceptors | 17 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 89 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1199.37 |
| LogP ≤ 5 | 13.65 |
| H-Bond Donors ≤ 5 | 5 |
| H-Bond Acceptors ≤ 10 | 17 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159623445 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.